´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.


* ¾Æ·¡ÀÇ ¼³¹® ³»¿ë¿¡ ´ëÇÏ¿© ¼º½ÇÈ÷ ´äº¯ ÇØÁÖ½Å, ¼¼ ºÐ ÀÇ °í°´²² ExiLERATE LNA qPCR Starter Kit (Code 303350)À» ¹«»ó Á¦°ø ±âȸ¸¦ µå¸³´Ï´Ù.

°³ÀÎÁ¤º¸ ¼öÁý ¹× ÀÌ¿ë¸ñÀû¿¡ µ¿ÀÇÇÏ°Ú½À´Ï´Ù.

* º» À̺¥Æ®¿¡ ÇØ´çµÇ´Â Á¦Ç°Àº Long non-coding RNA (lncRNA) ¶Ç´Â mRNA Real Time PCRÀ» À§ÇÑ Á¦Ç°ÀÔ´Ï´Ù.
* ÀÚ¼¼ÇÑ Á¦Ç° Á¤º¸´Â Á¦Ç° »ó¼¼Á¤º¸ ÆäÀÌÁö¿¡¼­ È®ÀÎÇϼ¼¿ä (¹Ù·Îº¸±â)

   1. °í°´ Á¤º¸
  *¼º¸í :
  *À̸ÞÀÏ :
  *¿¬¶ôó :
  *ȸ»ç/Çб³ :
  *ºÎ¼­ (¿¬±¸½Ç¸í) :
  ±³¼ö¸í (Ã¥ÀÓ¿¬±¸¿ø) :
  ´ë¸®Á¡ :


   Q1. ¿¬±¸ºÐ¾ß (º¹¼ö¼±Åà °¡´É)

Cancer Heart disease Infectious disease Non-infectious disease Neuroscience Stem cells
Development Toxicology Molecular diagnostics Other


   Q2. ÇöÀç RNA expression/regulation ½ÇÇèÀ» ÁøÇàÇÏ°í °è½Ê´Ï±î? (¾Æ·¡ ³»¿ë Áß Åà 1)

¿¹ ¾Æ´Ï¿À ¿¹Á¤ÀÌ´Ù


   Q2-1. Q2.¿¡¼­ "¿¹"¸¦ ¼±ÅÃÇϼ̴ٸé, ÇöÀç ÁøÇà ÁßÀ̽ŠRNA expression/regulation ½ÇÇèÀº ¹«¾ùÀԴϱî? (º¹¼ö¼±Åà °¡´É)

1. microRNA 2. mRNA 3. lncRNA 4. ±âŸ


   Q3. ÇöÀç RNA ½ÇÇè (mRNA ¹× non-coding RNA)À» À§ÇÏ¿© »ç¿ëÇÏ°í ÀÖ´Â ¹æ¹ý (qPCR ¶Ç´Â ±× ¿Ü) ¹× Á¦Ç°Àº ¹«¾ùÀԴϱî?
         (ÃÖ´ë 800ÀÚ ³»¿Ü ÀÛ¼º)


   Q4. ÇöÀç »ç¿ëÇÏ°í ÀÖ´Â ¹æ¹ýÀÇ Àå, ´ÜÁ¡À» ¼Ò°³ÇÏ¿©ÁֽʽÿÀ. (Àå/´ÜÁ¡ °¢°¢: ÃÖ´ë 400ÀÚ ³»¿Ü ÀÛ¼º)

ÀåÁ¡ :

´ÜÁ¡ :


   Q5. ExiqonÀ̶ó´Â ºê·£µå¸¦ ¾Ë°í °è½Ê´Ï±î?

¿¹ (¾Ë°ÔµÈ °æ·Î: ) ¾Æ´Ï¿À


   Q6. Exiqon ExiLERATE LNA Starter kitÀ» »ç¿ëÇÏ°íÀÚ ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀԴϱî? (Áß¿ä ÃÖ´ë 800ÀÚ ³»¿Ü ÀÛ¼º)


   Q7. ExiLERATE LNA qPCR Starter kit (Code 303350) ³»¿¡´Â cDNA ÇÕ¼º, qPCR SYBR premix ¹× GAPDH control primer°¡ Æ÷ÇÔ
        µÇ¾îÀÖ½À´Ï´Ù. ÇÏÁö¸¸ Target gene specific primer´Â Æ÷ÇԵǾîÀÖÁö ¾Ê½À´Ï´Ù. Custom ExiLERATE LNA qPCR primers (code
        309999)
¸¦ ±¸¸ÅÇÏ½Ç °èȹÀÌ ÀÖÀ¸½Ê´Ï±î?

¿¹ ¾Æ´Ï¿À


   Q8. ±âŸ (´ÙÄ«¶óÄÚ¸®¾Æ¿¡ ÀüÇÏ°í ½ÍÀº ¸»À» ÀÚÀ¯·ÎÀÌ ÀÛ¼ºÇØÁÖ¼¼¿ä)